Progestogens in renal cell carcinoma. A retrospective study.
A retrospective study of 88 cases of renal cell carcinoma is presented with emphasis on the follow-up and progestogens administration. Between the statistically homogeneous groups of patients treated with progesterone capronate and with other therapeutic regimens, no statistical difference in actuarial survival rate could be detected.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011374:Progesterone / Q000627:therapeutic use*; D012189:Retrospective Studies
D011374:Progesterone